ACETYLATOR PHENOTYPING OF TUBERCULOSIS PATIENTS USING MATRIX ISONIAZID OR SULFADIMIDINE AND ITS PROGNOSTIC SIGNIFICANCE FOR TREATMENT WITH SEVERAL INTERMITTENT ISONIAZID-CONTAINING REGIMENS

被引：49

作者：

ELLARD, GA ^{[1
]}

GAMMON, PT ^{[1
]}

机构：

[1] ROYAL POSTGRAD MED SCH,MRC,LAB STUDIES TB UNIT,LONDON W12 0HS,ENGLAND

来源：

关键词：

D O I：

10.1111/j.1365-2125.1977.tb00659.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：5 / 14

页数：10

共 32 条

[1] [Anonymous], 1975, Tubercle, V56, P81
[2] [Anonymous], 1973, Tubercle, V54, P23
[3] DYMOND L C, 1970, Clinica Chimica Acta, V27, P513, DOI 10.1016/0009-8981(70)90306-2
[4] ELLARD G A, 1973, Tubercle, V54, P57, DOI 10.1016/0041-3879(73)90015-9
[5] DETERMINATION OF ACETYLATOR PHENOTYPE USING MATRIX ISONIAZID
ELLARD, GA
GAMMON, PT
TIITINEN, H
[J]. TUBERCLE, 1975, 56 (03): : 203 - 209
[6] DETERMINATION OF ISONIAZID AND ITS METABOLITES ACETYLISONIAZID, MONOACETYLHYDRAZINE, DIACETYLHYDRAZINE, ISONICOTINIC ACID AND ISONICOTINYLGLYCINE IN SERUM AND URINE
ELLARD, GA
WALLACE, SM
GAMMON, PT
[J]. BIOCHEMICAL JOURNAL, 1972, 126 (03) : 449 - &
[7] PHARMACOKINETICS OF ISONIAZID METABOLISM IN MAN
ELLARD, GA
GAMMON, PT
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1976, 4 (02): : 83 - 113
[8] ELLARD GA, 1976, CLIN PHARMACOL THER, V19, P610
[9] ELLARD GA, IN PRESS
[10] EVANS D A P, 1969, Journal of Medical Genetics, V6, P405, DOI 10.1136/jmg.6.4.405